Medical Education Grants

Medical Education Grants is sponsored by Karyopharm Therapeutics. Karyopharm provides funding to eligible applicants requesting support for unbiased, evidence-based, independent medical education activities targeting unmet educational needs in multiple myeloma, endometrial cancer, and myelofibrosis.

Grants and Giving – Karyopharm Therapeutics Karyopharm is committed to supporting and partnering with the healthcare community to help advance scientific breakthroughs and improve the lives of patients with cancer and other serious diseases. We are committed to cancer research and treatment using novel first-in-class drugs directed against nuclear transport and related targets.

Karyopharm may provide funding to eligible applicants requesting support for unbiased, evidence-based, independent medical education activities targeting unmet educational needs in the areas of interest to the company. We support medical education grants in the following disease states: Multiple Myeloma (MM), Endometrial Cancer (EC), and Myelofibrosis (MF). Education grants are not provided to individuals or private group practices.

In addition, provision of education grants is not conditioned in any way on the use, purchase, prescription or recommendation of any current or future Karyopharm product. Questions and/or requests for consideration of medical education grants should be submitted using the Contact Form .

We consider requests to support activities or initiatives that provide Karyopharm with a tangible benefit (e.g., booth space, signage, etc.) in exchange for financial support.

The requests must be aligned with the Company’s areas of focus and be submitted by non-promotional, healthcare-related organizations such as academic or medical institutions, professional or scientific associations, medical education companies, or patient advocacy groups. The initiative must also seek to advance science and/or medicine; and funding must be requested from multiple supporters.

We focus our support on sponsorships that address need in any or all of the following disease states: Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Myelofibrosis (MF) and Endometrial Cancer. No sponsorship provided by Karyopharm is conditioned in any way on the use, purchase, prescription or recommendation of any current or future Karyopharm product.

Questions and/or requests for sponsorship support should be submitted using the Contact Form. We consider requests for charitable donations from bona fide charitable organizations focused on endeavors that seek to improve lives via health, science, education or humanitarian initiatives.

No charitable donation by Karyopharm is conditioned in any way on the use, purchase, prescription or recommendation of any current or future Karyopharm product. Questions and/or requests for charitable donations should be submitted using the Contact Form .